Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: From inflammation to autoimmunity and tissue damage/remodeling

Immunological Reviews

Volumn 233, Issue 1, 2010, Pages 267-285

  Manzo, Antonio ^a,b   Bombardieri, Michele ^a   Humby, Frances ^a   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Immune response; Lymphoid tissues; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; AMG 623; ANTIGOUT AGENT; ATACICEPT; AUTOANTIBODY; BAMINERCEPT; BELIMUMAB; CHEMOKINE; CYTOKINE; ETANERCEPT; INFLIXIMAB; OCRELIZUMAB; OFATUMUMAB; RITUXIMAB; TRU 015; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DIAGNOSTIC VALUE; DRUG MECHANISM; GENETIC RECOMBINATION; GOUT; HUMAN; INFLAMMATION; JOINT INJURY; LYMPH NODE; LYMPHATIC SYSTEM; LYMPHOID TISSUE; LYMPHOID TISSUE RESPONSE; NONHUMAN; ORGANOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SOMATIC MUTATION; SYNOVIUM; T LYMPHOCYTE; TISSUE INJURY; TISSUE REACTION; TREATMENT OUTCOME;

ADAPTIVE IMMUNITY; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CELL MOVEMENT; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LYMPHOCYTES; LYMPHOID TISSUE; PHENOTYPE; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE;

EID: 73249126744     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2009.00861.x     Document Type: Review

References (135)

1. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008 118 : 3537 3545.
2. Edwards JC, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004 350 : 2572 2581.
3. Kremer JM, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003 349 : 1907 1915.
4. Nepom GT. The role of the DR4 shared epitope in selection and commitment of autoreactive T cells in rheumatoid arthritis. Rheum Dis Clin North Am 2001 27 : 305 315.
5. Raychaudhuri S, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008 40 : 1216 1223.
6. Korganow AS, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999 10 : 451 461.
7. Verpoort KN, et al. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 2006 54 : 3799 3808.
8. Nielen MM, et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005 64 : 1199 1204.
9. Eberl G. From induced to programmed lymphoid tissues: the long road to preempt pathogens. Trends Immunol 2007 28 : 423 428.
10. Pabst R. Plasticity and heterogeneity of lymphoid organs. What are the criteria to call a lymphoid organ primary, secondary or tertiary? Immunol Lett 2007 112 : 1 8.
11. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 2006 176 : 5735 5739.
12. Wagner UG, et al. The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol 1998 161 : 6390 6397.
13. Le PL, et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009 182 : 3540 3547.
14. Manzo A, Caporali R, Montecucco C, Pitzalis C. Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response. Clin Exp Rheumatol 2003 21 : 501 508.
15. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000 177 : 134 140.
16. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005 5 : 617 628.
17. Mandik-Nayak L, Wipke BT, Shih FF, Unanue ER, Allen PM. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc Natl Acad Sci USA 2002 99 : 14368 14373.
18. Nosanchuk JS, Schnitzer B. Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study. Cancer 1969 24 : 243 254.
19. Mellors RC, Heimer R, Corcos J, Korngold L. Cellular origin of rheumatoid factor. J Exp Med 1959 110 : 875 886.
20. Imai Y, Sato T, Yamakawa M, Kasajima T, Suda A, Watanabe Y. A morphological and immunohistochemical study of lymphoid germinal centers in synovial and lymph node tissues from rheumatoid arthritis patients with special reference to complement components and their receptors. Acta Pathol Jpn 1989 39 : 127 134.
21. Burman A, et al. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 2005 174 : 1693 1700.
22. Polzer K, et al. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis 2008 67 : 1610 1616.
23. Zhang Q, et al. Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res Ther 2007 9 : R118.
24. Proulx ST, et al. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci 2007 1117 : 106 123.
25. Olszewski WL, Pazdur J, Kubasiewicz E, Zaleska M, Cooke CJ, Miller NE. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes. Arthritis Rheum 2001 44 : 541 549.
26. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med 2001 194 : 1375 1384.
27. Huh YM, Kim S, Suh JS, Song H, Song K, Shin KH. The role of popliteal lymph nodes in differentiating rheumatoid arthritis from osteoarthritis by using CE 3D FSPGR MR imaging: relationship of the inflamed synovial volume. Korean J Radiol 2005 6 : 117 124.
28. Guo, et al. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum 2009 60 : 2666 2676.
29. Manzo A, et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol 2007 171 : 1549 1562.
30. McCluggage WG, Bharucha H. Lymph node hyalinisation in rheumatoid arthritis and systemic sclerosis. J Clin Pathol 1994 47 : 138 142.
31. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol 2006 27 : 441 445.
32. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006 6 : 205 217.
33. Muehlenbachs A, Fried M, Lachowitzer J, Mutabingwa TK, Duffy PE. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J Immunol 2007 179 : 557 565.
34. Lee Y, et al. Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity 2006 25 : 499 509.
35. Nasr IW, Reel M, Oberbarnscheidt MH, et al. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant 2007 7 : 1071 1079.
36. Nacionales DC, et al. B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus. J Immunol 2009 182 : 4226 4236.
37. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 2006 25 : 643 654.
38. Moyron-Quiroz JE, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004 10 : 927 934.
39. Yu P, et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004 5 : 141 149.
40. Schrama D, et al. Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue. Cancer Immunol Immunother 2008 57 : 85 95.
41. Wengner AM, et al. CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum 2007 56 : 3271 3283.
42. Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 1989 42 : 1269 1271.
43. Genta RM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 1993 24 : 577 583.
44. Thaunat O, et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 2005 102 : 14723 14728.
45. Baddoura FK, Nasr IW, Wrobel B, Li Q, Ruddle NH, Lakkis FG. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005 5 : 510 516.
46. Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, Montecucco C. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum 2005 52 : 3448 3459.
47. Jimenez-Boj E, et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol 2005 175 : 2579 2588.
48. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006 116 : 3183 3194.
49. Yanni G, Whelan A, Feighery C, Bresnihan B. Analysis of cell populations in rheumatoid arthritis synovial tissues. Semin Arthritis Rheum 1992 21 : 393 399.
50. Manzo A, et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 2005 35 : 1347 1359.
51. Vos K, Thurlings RM, Wijbrandts CA, van SD, Gerlag DM, Tak PP. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis. Arthritis Rheum 2007 56 : 772 778.
52. Thurlings RM, Vos K, Wijbrandts CA, Zwinderman AH, Gerlag DM, Tak PP. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann Rheum Dis 2008 67 : 917 925.
53. Thurlings RM, et al. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum 2008 58 : 1582 1589.
54. Canete JD, et al. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis 2009 68 : 751 756.
55. Takemura S, et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001 167 : 1072 1080.
56. Yanni G, et al. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol 1993 93 : 387 395.
57. Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003 195 : 117 135. (Pubitemid 37153458)
58. Finke D, Schmutz S. Interleukin 7-induced lymphoid neogenesis in arthritis: recapitulation of a fetal developmental programme? Swiss Med Wkly 2008 138 : 500 505.
59. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003 3 : 292 303.
60. Marinkovic T, et al. Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest 2006 116 : 2622 2632.
61. Timmer TC, et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 2007 56 : 2492 2502.
62. Humby F, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009 6 : e1.
63. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000 12 : 471 481.
64. Luther SA, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002 169 : 424 433.
65. Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B-cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 2004 104 : 3021 3027.
66. Manzo A, et al. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum 2008 58 : 3377 3387.
67. Tsuji M, et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008 29 : 261 271.
68. van PN, Perret R, Prout M, Ronchese F, Le GG. Effector lymphoid tissue and its crucial role in protective immunity. Trends Immunol 2005 26 : 242 247.
69. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall TD. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 2007 104 : 10577 10582.
70. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003 3 : 867 878.
71. Canete JD, et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis 2007 66 : 720 726.
72. Salmi M, Rajala P, Jalkanen S. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest 1997 99 : 2165 2172.
73. Weninger W, et al. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003 170 : 4638 4648.
74. Pablos JL, et al. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells. BMC Immunol 2005 6 : 6.
75. Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005 106 : 444 446.
76. Link A, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007 8 : 1255 1265.
77. Page G, Miossec P. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J Pathol 2004 204 : 28 38.
78. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002 168 : 5333 5341.
79. Cantaert T, et al. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheum 2009 60 : 1944 1956.
80. Baeten D, Steenbakkers PG, Rijnders AM, Boots AM, Veys EM, De KF. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. Arthritis Rheum 2004 50 : 444 451.
81. Dorner T, Radbruch A. Selecting B cells and plasma cells to memory. J Exp Med 2005 201 : 497 499.
82. Manser T. Textbook germinal centers? J Immunol 2004 172 : 3369 3375.
83. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000 102 : 553 563.
84. Honjo T, Muramatsu M, Fagarasan S. AID: how does it aid antibody diversity? Immunity 2004 20 : 659 668.
85. Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003 424 : 103 107.
86. Barreto V, Reina-San-Martin B, Ramiro AR, McBride KM, Nussenzweig MC. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol Cell 2003 12 : 501 508.
87. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002 20 : 165 196.
88. Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1996 93 : 221 225.
89. Gause A, et al. The B lymphocyte in rheumatoid arthritis: analysis of rearranged V kappa genes from B cells infiltrating the synovial membrane. Eur J Immunol 1995 25 : 2775 2782.
90. Cantaert T, et al. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J Immunol 2008 181 : 785 794.
91. Muramatsu M, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999 274 : 18470 18476.
92. Liu YJ, et al. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J Exp Med 1997 185 : 165 170.
93. Hessian P, Lehnigk U, McKelvey K, vanderLinden P, Highton J, Ng B. Synovial CD21L expression, inflammation and prognosis in rheumatoid arthritis. Ann Rheum Dis 2008 67 (Suppl 2 156.
94. Schroder AE, Sieper J, Berek C. Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis. Mol Med 1997 3 : 260 272.
95. Klimiuk PA, Goronzy JJ, Bjornsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997 151 : 1311 1319.
96. Klimiuk PA, et al. Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann Rheum Dis 2003 62 : 472 475.
97. Klimiuk PA, et al. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. J Rheumatol 2005 32 : 1666 1672.
98. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology (Oxford) 2002 41 : 78 87.
99. Katakai T, et al. Spontaneous large-scale lymphoid neogenesis and balanced autoimmunity versus tolerance in the stomach of H+/K+-ATPase-reactive TCR transgenic mouse. J Immunol 2006 177 : 7858 7867.
100. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is b cell dependent. J Immunol 2001 167 : 4710 4718.
101. Karouzakis E, Neidhart M, Gay RE, Gay S. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006 106 : 8 13. (Pubitemid 44093056)
102. Kotake S, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001 44 : 1003 1012.
103. Hayer S, et al. B-cell infiltrates induce endosteal bone formation in inflammatory arthritis. J Bone Miner Res 2008 23 : 1650 1660.
104. Lisignoli G, et al. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 2006 206 : 78 85.
105. Sakai N, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006 103 : 14098 14103.
106. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003 200 : 500 503.
107. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 1998 188 : 1493 1501.
108. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998 101 : 273 281.
109. Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000 43 : 1831 1835.
110. Alessandri C, et al. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis 2004 63 : 1218 1221.
111. Kuhn KA, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006 116 : 961 973.
112. Kim HJ, Krenn V, Steinhauser G, Berek C. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol 1999 162 : 3053 3062.
113. Rantapaa-Dahlqvist S, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003 48 : 2741 2749.
114. Rosengren S, Wei N, Kalunian KC, Zvaifler NJ, Kavanaugh A, Boyle DL. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab. Arthritis Res Ther 2008 10 : R105.
115. Dong W, Li X, Feng Y, Fan C, Chen Z, Zhu P. The differential expressions of 78-kDa glucose regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitis. Arthritis Res Ther 2009 11 : R4.
116. Seyler TM, et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005 115 : 3083 3092.
117. Gregorio A, et al. Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) 2007 46 : 308 313.
118. Pitzalis C, Garrood T. From ubiquitous antigens to joint-specific inflammation: could local vascular permeability be the missing link? Trends Immunol 2006 27 : 299 302.
119. Klareskog L, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006 54 : 38 46.
120. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298 : 2199 2202.
121. Binstadt BA, et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006 7 : 284 292.
122. Kobayashi K, et al. Detection of Helicobacter pylori associated antigen and heat shock protein 60 on follicular dendritic cells in the germinal centres of low grade B cell lymphoma of gastric mucosa associated lymphoid tissue (MALT). J Clin Pathol 1998 51 : 396 398.
123. Coronella JA, et al. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 2002 169 : 1829 1836.
124. Weyand CM, Goronzy JJ. Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 2003 987 : 140 149.
125. Malone DG, Wahl SM, Tsokos M, Cattell H, Decker JL, Wilder RL. Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest 1984 74 : 1173 1185.
126. Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology (Oxford) 1999 38 : 1074 1080.
127. Boyle DL, Rosengren S, Kalunian K, Kavanaugh A. Synovial CXCL13 expression is associated with localized inflammation and predicts synovial response to rituximab in rheumatoid arthritis. Ann Rheum Dis 2009 68 (Suppl 3 134.
128. Cambridge G, et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003 48 : 2146 2154.
129. Kavanaugh A, et al. Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann Rheum Dis 2008 67 : 402 408.
130. Teng YK, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation. Ann Rheum Dis 2009 68 : 1011 1016.
131. Teng YK, et al. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum 2007 56 : 3909 3918.
132. Buch MH, et al. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Ann Rheum Dis 2009 68 : 1220 1227.
133. Armengol MP, et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine- containing active intrathyroidal germinal centers. Am J Pathol 2001 159 : 861 873.
134. Sims GP, Shiono H, Willcox N, Stott DI. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 2001 167 : 1935 1944.
135. Dorner T, Burmester GR. Co-evolution of new immunotherapeutics and anti-infective strategies. Curr Opin Rheumatol 2008 20 : 263 264.